North America Anti-Infective Agents Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Anti-Infective Agents Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Anti-Infective Agents Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Anti-Infective Agents Market Regional Analysis

6.2 North America Anti-Infective Agents Market Revenue 2019-2028 (US$ Million)

6.3 North America Anti-Infective Agents Market Forecast Analysis

7. North America Anti-Infective Agents Market Analysis – by Type

7.1 Anti-Viral

7.1.1 Overview
7.1.2 Anti-Viral: North America Anti-Infective Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Anti-Bacterial

7.2.1 Overview
7.2.2 Anti-Bacterial: North America Anti-Infective Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.3 Anti-Fungal

7.3.1 Overview
7.3.2 Anti-Fungal: North America Anti-Infective Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. North America Anti-Infective Agents Market Analysis – by Range

8.1 Narrow Spectrum and Broad Spectrum

8.1.1 Overview
8.1.2 Narrow Spectrum and Broad Spectrum: North America Anti-Infective Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. North America Anti-Infective Agents Market Analysis – by Route of Administration

9.1 IV

9.1.1 Overview
9.1.2 IV: North America Anti-Infective Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Oral

9.2.1 Overview
9.2.2 Oral: North America Anti-Infective Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.3 Topical

9.3.1 Overview
9.3.2 Topical: North America Anti-Infective Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. North America Anti-Infective Agents Market Analysis – by Indication

10.1 HIV

10.1.1 Overview
10.1.2 HIV: North America Anti-Infective Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)

10.2 Tuberculosis

10.2.1 Overview
10.2.2 Tuberculosis: North America Anti-Infective Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)

10.3 Respiratory Infection

10.3.1 Overview
10.3.2 Respiratory Infection: North America Anti-Infective Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)

10.4 Pneumonia

10.4.1 Overview
10.4.2 Pneumonia: North America Anti-Infective Agents Market – Revenue and Forecast, 2019-2028 (US$ Million)

11. North America Anti-Infective Agents Market – North America Analysis

11.1 Overview

11.2 North America

11.2.1 North America Anti-Infective Agents Market Breakdown, by Key Country, 2022 and 2028 (%)
11.2.1.1 North America Anti-Infective Agents Market – Revenue and Forecast Analysis – by Country
11.2.1.1 US: North America Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.1.1 US: North America Anti-Infective Agents Market Breakdown, by Type
11.2.1.1.2 US: North America Anti-Infective Agents Market Breakdown, by Range
11.2.1.1.3 US: North America Anti-Infective Agents Market Breakdown, by Route of Administration
11.2.1.1.4 US: North America Anti-Infective Agents Market Breakdown, by Indication

11.2.1.2 Canada: North America Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.2.1 Canada: North America Anti-Infective Agents Market Breakdown, by Type
11.2.1.2.2 Canada: North America Anti-Infective Agents Market Breakdown, by Range
11.2.1.2.3 Canada: North America Anti-Infective Agents Market Breakdown, by Route of Administration
11.2.1.2.4 Canada: North America Anti-Infective Agents Market Breakdown, by Indication

11.2.1.3 Mexico : North America Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.3.1 Mexico : North America Anti-Infective Agents Market Breakdown, by Type
11.2.1.3.2 Mexico : North America Anti-Infective Agents Market Breakdown, by Range
11.2.1.3.3 Mexico : North America Anti-Infective Agents Market Breakdown, by Route of Administration
11.2.1.3.4 Mexico : North America Anti-Infective Agents Market Breakdown, by Indication

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Abbott

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Allergan Plc.

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Astellas Pharma Inc.

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Bayer AG

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Boehringer Ingelheim International GmbH

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Bristol-Myers Squibb Company

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 F. Hoffmann-La Roche Ltd.

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Gilead Sciences, Inc.

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 GlaxoSmithKline plc.

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Merck & Co., Inc.

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

14.11 Novartis AG

14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

North America Anti-Infective Agents Market